Germ Cell Tumors and Treatment Strategies
8 Questions
0 Views

Germ Cell Tumors and Treatment Strategies

Created by
@AstonishedKansasCity

Podcast Beta

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the primary consensus regarding the use of high-dose chemotherapy (HDC) in first-line treatment for high-risk patients with germ cell tumors?

  • HDC significantly improves survival rates compared to standard treatments.
  • HDC is the only option for achieving long-term remission in high-risk cases.
  • HDC offers no benefit for high-risk patients in first-line treatment. (correct)
  • HDC is universally accepted for all stages of germ cell tumors.
  • What chemotherapy regimen has a long-term event-free survival (EFS) rate of 90% for advanced-disease, good-risk patients?

  • Carboplatin/epirubicin
  • Ifosfamide/vinblastine/cisplatin
  • Doxorubicin/ifosfamide/docetaxel
  • Bleomycin/etoposide/cisplatin (BEP) (correct)
  • Which factors affect long-term event-free survival rates in patients undergoing first relapse treatment for germ cell tumors?

  • Type of cancer and tumor size at diagnosis.
  • The stage of the tumor and previous treatment response. (correct)
  • The type of chemotherapy used and the patient's age.
  • Patient's genetic background and geographical location.
  • What technique has been improved in recent studies to support high-dose chemotherapy for relapse patients?

    <p>Autologous hematopoietic progenitor cell support (AHPCS).</p> Signup and view all the answers

    What is the reported event-free survival (EFS) rate for patients with second relapse who undergo tandem high-dose chemotherapy?

    <p>15%</p> Signup and view all the answers

    What is the main salvage regimen for treating germ cell tumor patients who have relapsed and is based on ifosfamide and cisplatin?

    <p>Etoposide, ifosfamide, and cisplatin (VIP).</p> Signup and view all the answers

    Which method was pioneered for the use of tandem high-dose chemotherapy cycles in treating refractory germ cell tumors?

    <p>Nichols et al. in the 1980s.</p> Signup and view all the answers

    What is the typical prognosis for patients classified as poor-risk using the International Germ Cell Consensus Classification (IGCCC)?

    <p>Long-term event-free survival around 50%.</p> Signup and view all the answers

    Study Notes

    Germ Cell Tumors (GCT)

    • Most common malignancy in young men (15-35 years old).
    • Standard first-line treatment with cisplatin-based chemotherapy achieves cure rates of 70-80% for metastatic disease.
    • Standard regimen bleomycin/etoposide/cisplatin (BEP) results in 90% long-term event-free survival (EFS) rates for advanced-disease, good-risk patients.
    • EFS rates decrease to 80% for intermediate-risk patients and 50% for poor-risk patients, according to the International Germ Cell Consensus Classification (IGCCC).
    • First relapse patients with standard salvage regimens have 50-60% CR rates and 20-30% long-term EFS.
    • Second relapse patients are largely incurable.

    High-dose Chemotherapy (HDC) for Refractory/Relapsed NSGCT

    • Tandem high-dose cycles of carboplatin/etoposide with autologous hematopoietic progenitor cell support (AHPCS) is used for salvage therapy.
    • Nichols et al. pioneered this approach in the 1980s.
    • Studies show long-term EFS rates as high as 15% for second-relapse patients and 38% for first-relapse patients.
    • Improvements in PBPC techniques and supportive measures have led to higher doses and better results.
    • Einhorn et al. found 68% EFS at a 48-month median follow-up in a recent study.
    • Outcome is similar in patients with seminoma and non-seminoma histologies.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    This quiz focuses on germ cell tumors (GCT), their prevalence in young men, and the standard treatments including chemotherapy regimens. It highlights the effectiveness of cisplatin-based therapy and the use of high-dose chemotherapy for relapsed cases. Test your knowledge on GCT statistics, treatment outcomes, and clinical classifications.

    More Like This

    PATH-C Disorders Male Reprod
    18 questions
    Patologia del ovario
    80 questions

    Patologia del ovario

    RestfulPraseodymium avatar
    RestfulPraseodymium
    Use Quizgecko on...
    Browser
    Browser